Ketamine analgesic effect by continuous intravenous infusion in refractory cancer pain: Considerations about the clinical research in palliative care

Journal of Palliative Medicine

Volumn 15, Issue 3, 2012, Pages 287-293

  Salas, Sébastien ^a   Frasca, Matthieu ^b   Planchet Barraud, Brigitte ^c   Burucoa, Benoît ^b   Pascal, Monique ^d   Lapiana, Jean Marc ^e   Hermet, Raymond ^f   Castany, Claudine ^g   Ravallec, Frédéric ^h   Loundou, Anderson ⁱ   Auquier, Pascal ^j   Duffaud, Florence ^a   Baumstarck, Karine ^i,j  

^a TIMONE HOSPITAL   (France)

^b HÔPITAL SAINT ANDRÉ   (France)

^c HÔPITAL SAINT JOSEPH   (France)

^d Centre de Lutte Contre la Douleur   (France)

^e Maison de Soins Palliatifs (La Maison)   (France)

^f UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^g Centre hospitalier de Salon de Provence   (France)

^h Hôpital Saint Thomas de Villeneuve   (France)

ⁱ ASSISTANCE PUBLIQUE HÔPITAUX DE MARSEILLE   (France)

^j AIX MARSEILLE UNIVERSITY   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

KETAMINE; MORPHINE; OPIATE; PLACEBO;

ADULT; ANALGESIA; ANALGESIC ACTIVITY; ANXIETY; ARTICLE; CANCER PAIN; CANCER PALLIATIVE THERAPY; CANCER RESEARCH; CLINICAL ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DECREASED APPETITE; DEPRESSION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DROWSINESS; DRUG EFFICACY; DRUG RESPONSE; DYSPNEA; FATIGUE; FEMALE; HUMAN; LOADING DRUG DOSE; MALE; MULTICENTER STUDY; NAUSEA; PAIN ASSESSMENT; PATIENT SATISFACTION; RANDOMIZED CONTROLLED TRIAL; SELF CONCEPT; SELF REPORT; SIDE EFFECT; SOMNOLENCE;

ADULT; AGED; ANALGESICS; BIOMEDICAL RESEARCH; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; KETAMINE; MALE; MIDDLE AGED; NEOPLASMS; OUTCOME ASSESSMENT (HEALTH CARE); PAIN, INTRACTABLE; PALLIATIVE CARE;

EID: 84858131039     PISSN: 10966218     EISSN: 15577740     Source Type: Journal    
DOI: 10.1089/jpm.2011.0353     Document Type: Article

References (32)

1. Kissin I, Bright CA, Bradley EL: The effect of ketamine on opioid-induced acute tolerance: Can it explain reduction of opioid consumption with ketamine-opioid analgesic combinations? Anesth Analg 2000;91:1483-1488.
2. Bossard AE, Guirimand F, Fletcher D, Gaude-Joindreau V, Chauvin M, Bouhassira D: Interaction of a combination of morphine and ketamine on the nociceptive flexion reflex in human volunteers. Pain 2002;98:47-57. (Pubitemid 34722468)
3. Fisher K, Coderre TJ, Hagen NA: Targeting the N-methyl- D-aspartate receptor for chronic pain management. Preclinical animal studies, recent clinical experience and future research directions. J Pain Symptom Manage 2000; 20:358-373.
4. Laulin JP, Maurette P, Corcuff JB, Rivat C, Chauvin M, Simonnet G: The role of ketamine in preventing fentanylinduced hyperalgesia and subsequent acute morphine tolerance. Anesth Analg 2002;94:1263-1269, table of contents. (Pubitemid 34441848)
5. McDonnell FJ, Sloan JW, Hamann SR: Advances in cancer pain management. Curr Pain Headache Rep 2001;5:265-271.
6. Mao J, Price DD, Mayer DJ: Mechanisms of hyperalgesia and morphine tolerance: A current view of their possible interactions. Pain 1995;62:259-274.
7. Ahmedzai S: New approaches to pain control in patients with cancer. Eur J Cancer 1997;33(Suppl 6):S8-S14.
8. Bell RF, Eccleston C, Kalso E: Ketamine as adjuvant to opioids for cancer pain. A qualitative systematic review. J Pain Symptom Manage 2003;26:867-875. (Pubitemid 37101234)
9. Fine PG: Low-dose ketamine in the management of opioid nonresponsive terminal cancer pain. J Pain Symptom Manage 1999;17:296-300.
10. Clark JL, Kalan GE: Effective treatment of severe cancer pain of the head using low-dose ketamine in an opioid-tolerant patient. J Pain Symptom Manage 1995;10:310-314.
11. Klepstad P, Borchgrevink P, Hval B, Flaat S, Kaasa S: Longterm treatment with ketamine in a 12-year-old girl with severe neuropathic pain caused by a cervical spinal tumor. J Pediatr Hematol Oncol 2001;23:616-619. (Pubitemid 34073870)
12. Lloyd-Williams M: Ketamine for cancer pain. J Pain Symptom Manage 2000;19:79-80.
13. Roberts LJ, Goucke CR: Retro-orbital tumour-an uncommon cause of headache in pregnancy. Anaesth Intensive Care 2001;29:276-280. (Pubitemid 32600101)
14. Slatkin NE, Rhiner M: Topical ketamine in the treatment of mucositis pain. Pain Med 2003;4:298-303.
15. Mercadante S, Arcuri E, Tirelli W, Casuccio A: Analgesic effect of intravenous ketamine in cancer patients on morphine therapy: A randomized, controlled, double-blind, crossover, double-dose study. J Pain Symptom Manage 2000; 20:246-252.
16. Lauretti GR, Lima IC, Reis MP, Prado WA, Pereira NL: Oral ketamine and transdermal nitroglycerin as analgesic adjuvants to oral morphine therapy for cancer pain management. Anesthesiology 1999;90:1528-1533. (Pubitemid 29254794)
17. Lauretti GR, Gomes JM, Reis MP, Pereira NL: Low doses of epidural ketamine or neostigmine, but not midazolam, improve morphine analgesia in epidural terminal cancer pain therapy. J Clin Anesth 1999;11:663-668. (Pubitemid 30064448)
18. Yang CY, Wong CS, Chang JY, Ho ST: Intrathecal ketamine reduces morphine requirements in patients with terminal cancer pain. Can J Anaesth 1996;43:379-383.
19. Law no. 99-477 on palliative care. June 9, 1999. Guaranteed access to palliative care. www.adminet.com/jo/19990610 [Last accessed September 12, 2011.]
20. World Health Organization: WHO's pain ladder. www .who.int/cancer/ palliative/painladder/en/ [Last accessed May 9, 2011.]
21. Johns MW: Reliability and factor analysis of the Epworth Sleepiness Scale. Sleep 1992;15:376-381.
22. AHCPR: Acute pain management: Operative or medical procedures and trauma. Clinical Practice Guideline No. 1. No. 92-0032. Rockville, MD: AHCPR, 1992.
23. Hartrick CT, Kovan JP, Shapiro S: The numeric rating scale for clinical pain measurement: A ratio measure? Pain Pract 2003;3:310-316.
24. Johnson C: Measuring Pain. Visual analog scale versus numeric pain scale: What is the difference? J Chiropr Med 2005;4:43-44.
25. Bruera E, Kuehn N, Miller MJ, Selmser P, Macmillan K: The Edmonton Symptom Assessment System (ESAS): A simple method for the assessment of palliative care patients. J Palliat Care 1991;7:6-9.
26. Clark ME, Gironda RJ, Young RW: Development and validation of the Pain Outcomes Questionnaire-VA. J Rehabil Res Dev 2003;40:381-395. (Pubitemid 37314962)
27. Evans CJ, Trudeau E, Mertzanis P, Marquis P, Pena BM, Wong J, Mayne T: Development and validation of the Pain Treatment Satisfaction Scale (PTSS): A patient satisfaction questionnaire for use in patients with chronic or acute pain. Pain 2004;112:254-266. (Pubitemid 39550725)
28. Mo SL, Liu YH, Duan W, Wei MQ, Kanwar JR, Zhou SF: Substrate specificity, regulation, and polymorphism of human cytochrome P450 2B6. Curr Drug Metab 2009;10:730-753.
29. Restrepo JG, Garcia-Martin E, Martinez C, Agundez JA: Polymorphic drug metabolism in anaesthesia. Curr Drug Metab 2009;10:236-246.
30. Frasca M, Salas S: Thoughts on clinical research in palliative care: On a therapeutic trial of the analgesic effect of the ketamine-morphine combination. Med Palliat 2009;8:7-14.
31. Speck P: Consideration of consent in clinical research. Palliat Med 1996;10:163-164.
32. Richards MA, Corner J, Clark D: Developing a research culture for palliative care. Palliat Med 1998;12:399-403. (Pubitemid 28454409)